Huber Capital Management LLC Decreases Stake in Utah Medical Products, Inc. $UTMD

Huber Capital Management LLC reduced its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 23.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 36,840 shares of the medical instruments supplier’s stock after selling 11,012 shares during the period. Huber Capital Management LLC’s holdings in Utah Medical Products were worth $2,062,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Segall Bryant & Hamill LLC purchased a new stake in shares of Utah Medical Products in the third quarter worth about $726,000. Brandes Investment Partners LP lifted its position in shares of Utah Medical Products by 4.0% in the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock worth $19,660,000 after buying an additional 13,392 shares in the last quarter. Russell Investments Group Ltd. lifted its position in shares of Utah Medical Products by 47.1% in the third quarter. Russell Investments Group Ltd. now owns 4,057 shares of the medical instruments supplier’s stock worth $255,000 after buying an additional 1,299 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Utah Medical Products by 1.3% in the third quarter. Dimensional Fund Advisors LP now owns 200,032 shares of the medical instruments supplier’s stock worth $12,596,000 after buying an additional 2,566 shares in the last quarter. Finally, Isthmus Partners LLC lifted its position in shares of Utah Medical Products by 13.3% in the third quarter. Isthmus Partners LLC now owns 38,283 shares of the medical instruments supplier’s stock worth $2,411,000 after buying an additional 4,488 shares in the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Price Performance

Shares of NASDAQ UTMD opened at $67.84 on Friday. The business’s 50 day moving average is $66.09 and its two-hundred day moving average is $62.73. Utah Medical Products, Inc. has a 1-year low of $52.00 and a 1-year high of $71.81. The stock has a market capitalization of $215.73 million, a P/E ratio of 20.07 and a beta of 0.37.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. Utah Medical Products had a return on equity of 9.13% and a net margin of 28.90%.The company had revenue of $8.72 million for the quarter.

Utah Medical Products Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 3rd. Shareholders of record on Wednesday, June 17th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Wednesday, June 17th. Utah Medical Products’s payout ratio is presently 36.69%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Utah Medical Products in a research report on Friday, May 22nd. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Utah Medical Products has a consensus rating of “Hold”.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).